—

Sarissa Capital Management LP

Q4 2025 13F Holdings

  • Location
    greenwich, CT
  • Num holdings

    9

  • Value ($000)

    $222,909

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001577524
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
I
INVA

INNOVIVA INC

COM
45781M101
$56.29M
25 %

2,816,022

I
IRWD

IRONWOOD PHARMACEUTICALS INC

COM CL A
46333X108
$53.65M
24 %

15,919,435

N
NBIX

NEUROCRINE BIOSCIENCES INC

COM
64125C109
$43M
19 %

303,151

C
CYTK

CYTOKINETICS INC

COM NEW
23282W605
$25.18M
11 %

396,357

---

AMARIN CORP PLC

SPONSORED ADR
023111404
$23.35M
11 %

1,673,395

L
LNTH

LANTHEUS HLDGS INC

COM
516544103
$12.08M
5 %

181,450

---

BIOHAVEN LTD

COM
G1110E107
$5.79M
3 %

513,184

R
REGN

REGENERON PHARMACEUTICALS

COM
75886F107
$3.23M
2 %

4,190

---

VOR BIOPHARMA INC

COM NEW
929033207
$332.22K
0 %

25,399

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 9 of 9